Wells Fargo & Company MN Acquires 2,247 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Wells Fargo & Company MN increased its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 1.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,678 shares of the company’s stock after buying an additional 2,247 shares during the period. Wells Fargo & Company MN owned 0.37% of Phibro Animal Health worth $3,143,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PAHC. Vanguard Group Inc. grew its stake in shares of Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock worth $31,809,000 after acquiring an additional 20,604 shares during the last quarter. American Century Companies Inc. grew its position in Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after purchasing an additional 96,787 shares during the last quarter. Geode Capital Management LLC increased its stake in Phibro Animal Health by 1.7% during the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock valued at $10,838,000 after purchasing an additional 8,510 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Phibro Animal Health by 35.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 322,090 shares of the company’s stock worth $6,764,000 after buying an additional 84,599 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Phibro Animal Health by 8.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company’s stock worth $6,104,000 after buying an additional 22,263 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 0.9 %

Shares of Phibro Animal Health stock opened at $17.20 on Thursday. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a twelve month low of $12.30 and a twelve month high of $26.55. The company has a market cap of $696.65 million, a price-to-earnings ratio of 35.83, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. The company’s 50 day moving average is $20.96 and its 200 day moving average is $22.19.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Research analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.79%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

Analyst Upgrades and Downgrades

PAHC has been the subject of several analyst reports. Morgan Stanley set a $20.00 price target on shares of Phibro Animal Health in a research report on Tuesday, April 15th. Barclays lifted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Finally, StockNews.com downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.75.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.